share_log

CVS Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

CVS Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

西维斯健康 | S-8：员工福利计划证券登记
美股sec公告 ·  05/23 16:40
Moomoo AI 已提取核心信息
On May 22, 2024, CVS Health Corporation filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) to register an additional 33,500,000 shares of common stock for its 2017 Incentive Compensation Plan. This filing is in accordance with General Instruction E to Form S-8 and follows previous registrations of shares for the same plan in 2017 and 2020. The newly registered shares are intended for sale to participants under the plan, which aims to incentivize and retain key employees by allowing them to acquire a proprietary interest in the company. The Registration Statement incorporates by reference the company's previous filings, including its Annual Report for the fiscal year ended December 31, 2023, and its Quarterly Report for the period ended March 31, 2024. The Plan includes provisions for various types of awards, including options, stock appreciation rights, and restricted stock, with specific clauses addressing the effects of a Change in Control on award vesting.
On May 22, 2024, CVS Health Corporation filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) to register an additional 33,500,000 shares of common stock for its 2017 Incentive Compensation Plan. This filing is in accordance with General Instruction E to Form S-8 and follows previous registrations of shares for the same plan in 2017 and 2020. The newly registered shares are intended for sale to participants under the plan, which aims to incentivize and retain key employees by allowing them to acquire a proprietary interest in the company. The Registration Statement incorporates by reference the company's previous filings, including its Annual Report for the fiscal year ended December 31, 2023, and its Quarterly Report for the period ended March 31, 2024. The Plan includes provisions for various types of awards, including options, stock appreciation rights, and restricted stock, with specific clauses addressing the effects of a Change in Control on award vesting.
2024年5月22日，CVS Health Corporation向美国证券交易委员会（SEC）提交了S-8表格的注册声明，要求为其2017年激励性薪酬计划再注册33,500,000股普通股。该申报符合S-8表格E的一般指令，并遵循了先前在2017年和2020年为同一计划注册的股份。根据该计划，新注册的股票将出售给参与者，该计划旨在通过允许关键员工收购公司的专有权益来激励和留住他们。注册声明以引用方式纳入了公司先前提交的文件，包括截至2023年12月31日的财政年度的年度报告和截至2024年3月31日的季度报告。该计划包括各种奖励的条款，包括期权、股票增值权和限制性股票，并有具体条款涉及控制权变更对奖励归属的影响。
2024年5月22日，CVS Health Corporation向美国证券交易委员会（SEC）提交了S-8表格的注册声明，要求为其2017年激励性薪酬计划再注册33,500,000股普通股。该申报符合S-8表格E的一般指令，并遵循了先前在2017年和2020年为同一计划注册的股份。根据该计划，新注册的股票将出售给参与者，该计划旨在通过允许关键员工收购公司的专有权益来激励和留住他们。注册声明以引用方式纳入了公司先前提交的文件，包括截至2023年12月31日的财政年度的年度报告和截至2024年3月31日的季度报告。该计划包括各种奖励的条款，包括期权、股票增值权和限制性股票，并有具体条款涉及控制权变更对奖励归属的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息